<産業資料/調査レポートの題名> 2022年4月19日

CBDスキンケアの世界市場2020-2024


◆英文タイトル:Global CBD Skincare Market 2020-2024

01: EXECUTIVE SUMMARY
02: SCOPE OF THE REPORT
1. 2.1 Preface
2. 2.2 Preface
3. 2.3 Currency conversion rates for US$
03: MARKET LANDSCAPE
4. Market ecosystem
5. Market characteristics
6. Market segmentation analysis
7. Value chain analysis
04: MARKET SIZING
8. Market definition
9. Market sizing 2019
10. Market size and forecast 2019-2024
11. Market outlook
05: FIVE FORCES ANALYSIS
12. Bargaining power of buyers
13. Bargaining power of suppliers
14. Threat of new entrants
15. Threat of substitutes
16. Threat of rivalry
17. Market condition
06: MARKET SEGMENTATION BY END-USER
18. Market segmentation by end-user
19. Comparison by end-user
20. Pharmaceutical companies – Market size and forecast 2019-2024
21. Other organizations – Market size and forecast 2019-2024
22. Market opportunity by end-user
07: CUSTOMER LANDSCAPE
08: GEOGRAPHIC LANDSCAPE
23. Geographic segmentation
24. Geographic comparison
25. North America – Market size and forecast 2019-2024
26. Europe – Market size and forecast 2019-2024
27. Asia – Market size and forecast 2019-2024
28. ROW – Market size and forecast 2019-2024
29. Key leading countries
30. Market opportunity
09: DECISION FRAMEWORK
10: DRIVERS AND CHALLENGES
31. Market drivers
32. Market challenges
11: MARKET TRENDS
33. Advent of AI in clinical research
34. Increasing outsourcing activities to CROs
35. Increasing adoption of cloud technologies in pharmaceutical production
36. and testing
12: VENDOR LANDSCAPE
37. Overview
38. Landscape disruption
39. Competitive scenario
13: VENDOR ANALYSIS
40. Vendors covered
41. Vendor classification
42. Market positioning of vendors
43. Bilcare Ltd.
44. Caligor Coghlan Pharma Services
45. Corden Pharma International GmbH
46. Mawdsley-Brooks & Co. Ltd.
47. PCI Pharma Services
48. Piramal Enterprises Ltd.
49. Sentry BioPharma Services
50. Sharp
51. The WestRock group
52. Thermo Fisher Scientific Inc.
14: APPENDIX
53. Research methodology
54. List of abbreviations
55. Definition of market positioning of vendors
15: EXPLORE TECHNAVIO


Exhibit 01: Vendors: Key offerings
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: End-user – Market share 2019-2024 (%)
Exhibit 19: Comparison by end-user
Exhibit 20: Pharmaceutical companies – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Pharmaceutical companies – Year-over-year growth 2020-2024 (%)
Exhibit 22: Other organizations – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Other organizations – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by end-user
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America – Year-over-year growth 2020-2024 (%)
Exhibit 30: Top 3 countries in North America
Exhibit 31: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 32: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 33: Top 3 countries in Europe
Exhibit 34: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 36: Top 3 countries in Asia
Exhibit 37: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 38: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 39: Top 3 countries in ROW
Exhibit 40: Key leading countries
Exhibit 41: Market opportunity
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Bilcare Ltd. – Vendor overview
Exhibit 49: Bilcare Ltd. – Business segments
Exhibit 50: Bilcare Ltd. – Key offerings
Exhibit 51: Bilcare Ltd. – Key customers
Exhibit 52: Caligor Coghlan Pharma Services – Vendor overview
Exhibit 53: Caligor Coghlan Pharma Services – Business segments
Exhibit 54: Caligor Coghlan Pharma Services – Organizational developments
Exhibit 55: Caligor Coghlan Pharma Services – Key offerings
Exhibit 56: Caligor Coghlan Pharma Services – Key customers
Exhibit 57: Corden Pharma International GmbH – Vendor overview
Exhibit 58: Corden Pharma International GmbH – Business segments
Exhibit 59: Corden Pharma International GmbH – Organizational developments
Exhibit 60: Corden Pharma International GmbH – Key offerings
Exhibit 61: Corden Pharma International GmbH – Key customers
Exhibit 62: Mawdsley-Brooks & Co. Ltd. – Vendor overview
Exhibit 63: Mawdsley-Brooks & Co. Ltd. – Business segments
Exhibit 64: Mawdsley-Brooks & Co. Ltd. – Organizational developments
Exhibit 65: Mawdsley-Brooks & Co. Ltd. – Key offerings
Exhibit 66: Mawdsley-Brooks & Co. Ltd. – Key customers
Exhibit 67: PCI Pharma Services – Vendor overview
Exhibit 68: PCI Pharma Services – Business segments
Exhibit 69: PCI Pharma Services – Organizational developments
Exhibit 70: PCI Pharma Services – Key offerings
Exhibit 71: PCI Pharma Services – Key customers
Exhibit 72: Piramal Enterprises Ltd. – Vendor overview
Exhibit 73: Piramal Enterprises Ltd. – Business segments
Exhibit 74: Piramal Enterprises Ltd. – Organizational developments
Exhibit 75: Piramal Enterprises Ltd. – Segment focus
Exhibit 76: Piramal Enterprises Ltd. – Key offerings
Exhibit 77: Piramal Enterprises Ltd. – Key customers
Exhibit 78: Sentry BioPharma Services – Vendor overview
Exhibit 79: Sentry BioPharma Services – Business segments
Exhibit 80: Sentry BioPharma Services – Key offerings
Exhibit 81: Sentry BioPharma Services – Key customers
Exhibit 82: Sharp – Vendor overview
Exhibit 83: Sharp – Business segments
Exhibit 84: Sharp – Organizational developments
Exhibit 85: Sharp – Geographic focus
Exhibit 86: Sharp – Key offerings
Exhibit 87: Sharp – Key customers
Exhibit 88: The WestRock group – Vendor overview
Exhibit 89: The WestRock group – Business segments
Exhibit 90: The WestRock group – Organizational developments
Exhibit 91: The WestRock group – Segment focus
Exhibit 92: The WestRock group – Key offerings
Exhibit 93: The WestRock group – Key customers
Exhibit 94: Thermo Fisher Scientific Inc. – Vendor overview
Exhibit 95: Thermo Fisher Scientific Inc. – Business segments
Exhibit 96: Thermo Fisher Scientific Inc. – Organizational developments
Exhibit 97: Thermo Fisher Scientific Inc. – Geographic focus
Exhibit 98: Thermo Fisher Scientific Inc. – Segment focus
Exhibit 99: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 100: Thermo Fisher Scientific Inc. – Key customers
Exhibit 101: Validation techniques employed for market sizing
Exhibit 102: Definition of market positioning of vendors


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark